Clinical Trial Update: Markers of Anthracycline-Related Cardiac Muscle Injury

View source ↗

Summary

The clinical trial NCT01112800 evaluating markers of anthracycline-related cardiac muscle injury in pediatric sarcoma patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Non-rhabdomyosarcoma Soft Tissue Sarcoma
• Osteosarcoma
• Rhabdomyosarcoma

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Osteosarcoma, Ewing's Sarcoma Family of Tumors | Status: WITHDRAWN